Altamira Therapeutics Ltd. Gains 58.64%
Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $0.52, representing a gain of 58.6%. On Fri, Oct 21, 2022, CYTO:NASDAQ hit a New 2-Week High of $0.52. The stock appeared on our News Catalysts scanner on Thu, Oct 13, 2022 at 12:33 PM in the 'MISCELLANEOUS' category. From Fri, Oct 07, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Oct 21, 2022 at $0.68 with a volume of 79M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 89.27%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 58.64%
- Missfresh Limited (MF:NASDAQ), 57.5%
- Enservco Corporation (ENSV:NYSEMKT), 37.42%
- Renovare Environmental Inc. (RENO:NASDAQ), 33.33%
- Kaleyra Inc. (KLR:NYSE), 24.85%
- Veris Residential Inc. (VRE:NYSE), 23.27%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 22.15%
- Candel Therapeutics Inc. (CADL:NASDAQ), 21.62%
- Energy Focus, Inc. (EFOI:NASDAQ), 21.47%